Release Date: 28/08/15 16:31 Summary: Broker Presentation - August 2015 Price Sensitive: No Download Document 1.37MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%